Prostate cancer patients treated with Androgen Deprivation Therapy, the testosterone-lowering drugs, are twice likely to develop dementia than patients who didn't receive testosterone medication, reports a recent study.
Prostate cancer patients treated with Androgen Deprivation Therapy, the testosterone-lowering drugs, are twice likely to develop dementia than patients who didn't receive testosterone medication, reports a recent study.
Please to comment